Kumar T, Hobbs E, Yang F, Chang JT, et al. Tumor immune microenvironment changes by multiplex immunofluorescence staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a hereditary BRCA mutation. Clin Cancer Res 2022 Jun 23. pii: 705099. doi: 10.1158/1078-0432.CCR-21-1278.
PMID: 35736816